BioLife Solutions Inc (BLFS)

NasdaqCM • Currently showing stable movement in today's trading session

1 member of Congress has disclosed 6 trades in BioLife Solutions Inc (BLFS) via STOCK Act filings. The most recent disclosure was a purchase by Tom Malinowski on 7 July 2020. Aggregate disclosed activity totals roughly $121.5K in purchases (midpoint estimates from bracketed disclosure amounts).

BioLife Solutions Inc is currently trading at $38.61, positioned at 95% of its 52-week range ($17.86 – $39.76).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$38.61
24h Change
-
52 Week Range
$17.86–$39.76
View on NASDAQ

BioLife Solutions Inc Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for BLFS

Select to highlight on chart
5 transactions
Compliance: 33%
Tom Malinowski7 Jul 20205 Mar 2021PurchaseStock$1,001 - $15,000N/A
Tom Malinowski7 Jul 202030 Jul 2021PurchaseStock$1,001 - $15,000N/A
Tom Malinowski7 Jul 202026 Aug 2021PurchaseStock$1,001 - $15,000N/A
Tom Malinowski17 Jun 202030 Jul 2021PurchaseStock$15,001 - $50,000N/A
Tom Malinowski17 Jun 202026 Aug 2021PurchaseStock$15,001 - $50,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$1.89B

Volume

4.39M

Beta

1.92

P/E Ratio

37.49

Fundamentals

EPS

$1.03

Div. Yield

-

Open

$37.16

Day Range

$37.00 – $38.83

Company Information

Sector
Healthcare
Industry
Medical - Instruments & Supplies
Exchange
NASDAQ · USD
Country
US
CEO
Roderick de Greef
IPO Date
1989-11-22
Website
www.biolifesolutions.com

BioLife Solutions, Inc. (BLFS) operates as a global provider of specialized bioproduction tools and services, primarily catering to the cell and gene therapy industry. Its market reach extends across the United States, Canada, Europe, the Middle East...

Earnings

Next Report

Q3 2026

5 Nov

EPS Est.

$0.05

Rev. Est.

$29.1M

Days Until

21

Recent Quarters

Q2 20266 Aug
EPS$0.91
Beat 2812.0%
Q1 20267 May
EPS$0.04
Beat 300.0%
Q4 202526 Feb
EPS$0.04
Beat 300.0%
Q3 20256 Nov
EPS$0.04
Beat 1900.0%
Q2 20257 Aug
EPS$-0.33
Miss 1550.0%
Q1 20258 May
EPS$0.04
Beat 233.3%
Q4 20243 Mar
EPS$-0.01
Beat 83.3%
Q3 202412 Nov
EPS$-0.02
Beat 77.8%
Q2 20248 Aug
EPS$-0.16
Miss 14.3%
Q1 20249 May
EPS$-0.23
Beat 17.9%
Q4 202329 Feb
EPS$-0.30
Beat 11.8%
Q3 20239 Nov
EPS$-0.67
Miss 76.3%
Q2 20238 Aug
EPS$-0.23
Miss 15.0%
Q1 202310 May
EPS$-0.32
Miss 52.4%
Q4 202216 Mar
EPS$-1.15
Miss 576.5%
Q3 20229 Nov
EPS$-0.23
Miss 35.3%
Q2 20229 Aug
EPS$-1.71
Miss 755.0%
Q1 20229 May
EPS$-0.17
Beat 32.0%
Q4 202128 Feb
EPS$-0.37
Miss 117.7%
Q3 202111 Nov
EPS$0.00
Beat 102.1%
Q2 202112 Aug
EPS$0.19
Beat 480.0%
Q1 202113 May
EPS$-0.03
Beat 25.0%
Q4 202022 Mar
EPS$-0.06
Miss 200.0%
Q3 20205 Nov
EPS$-0.04
Beat 0.0%
Q2 20206 Aug
EPS$-0.70
Miss 1650.0%
Q1 202014 May
EPS$1.06
Beat 5400.0%
Q4 201911 Mar
EPS$0.02
Beat 200.0%
Q3 201912 Nov
EPS$0.01
Beat 0.0%
Q2 20198 Aug
EPS$0.04
Beat 100.0%
Q1 20199 May
EPS$0.03
Miss 25.0%
Q4 201814 Mar
EPS$0.04
Miss 20.0%
Q3 20188 Nov
EPS$0.05
Beat 25.0%
Q2 20189 Aug
EPS$0.05
Beat 25.0%
Q1 201810 May
EPS$-0.01
Beat 66.7%
Q4 20178 Mar
EPS$-0.05
Miss 25.0%
Q3 20179 Nov
EPS$-0.03
Beat 50.0%
Q2 201710 Aug
EPS$-0.06
Miss 50.0%
Q1 201711 May
EPS$-0.07
Miss 16.7%
Q4 20169 Mar
EPS$-0.26
Miss 225.0%
Q3 201610 Nov
EPS$-0.08
Beat 0.0%
Q2 201611 Aug
EPS$-0.11
Miss 37.5%
Q1 201612 May
EPS$-0.10
Miss 25.0%
Q4 201525 Feb
EPS$-0.09
Beat 10.0%
Q3 201512 Nov
EPS$-0.09
Beat 10.0%
Q2 20156 Aug
EPS$-0.08
Beat 20.0%
Q1 20157 May
EPS$-0.09
Beat 0.0%
Q4 201412 Mar
EPS$-0.08
Miss 14.3%
Q3 20146 Nov
EPS$-0.07
Miss 40.0%
Q2 20147 Aug
EPS$-0.07
Miss 75.0%
Q1 20148 May
EPS$-0.10
Miss 1100.0%
Q4 201312 Feb
EPS$-0.10
Miss 42.9%
Q3 201314 Nov
EPS$-0.06
Beat 55.8%
Q2 201312 Aug
EPS$-0.06
Beat 59.6%
Q1 201314 May
EPS$-0.00
Q1 20131 Apr
EPS$-0.14
Q3 201213 Nov
EPS$-0.14
Beat 0.0%
Q2 201214 Aug
EPS$-0.10
Q1 201214 May
EPS$-0.06
Q4 201129 Mar
EPS$-0.08
Q3 201114 Nov
EPS$-0.10
Q2 201112 Aug
EPS$-0.09
Q1 201116 May
EPS$-0.12
Q4 201028 Mar
EPS$-0.09
Q3 201015 Nov
EPS$-0.09
Q2 201013 Aug
EPS$-0.11
Q1 201013 May
EPS$-0.11
Q4 200930 Mar
EPS$-0.07
Q3 200913 Nov
EPS$-0.11
Q2 200914 Aug
EPS$-0.20
Q1 200914 May
EPS$-0.17
Q4 200831 Mar
EPS$-0.16
Q3 200810 Nov
EPS$-0.13
Q2 200813 Aug
EPS$-0.13
Q1 200813 May
EPS$-0.13
Q1 20081 Apr
EPS$-0.15
Q3 200714 Nov
EPS$-0.15
Q2 200714 Aug
EPS$-0.15
Q1 200715 May
EPS$-0.12
Q1 20072 Apr
EPS$-0.01
Q3 20068 Nov
EPS$-0.08
Q2 200614 Aug
EPS$-0.11
Q1 200619 May
EPS$-0.24
Q1 200614 Apr
EPS$-0.19
Q3 200514 Nov
EPS$-0.18
Q2 200515 Aug
EPS$-0.15
Q1 200516 May
EPS$-0.18
Q4 200431 Mar
EPS$-0.11
Q3 200415 Nov
EPS$-0.17
Q2 200412 Aug
EPS$-0.26
Q1 200414 May
EPS$-0.29
Q1 200414 Apr
EPS$-0.52
Q3 200314 Nov
EPS$-0.64
Q2 200314 Aug
EPS$-0.56
Q1 200315 May
EPS$-0.38
Q1 200315 Apr
EPS$-0.33
Q3 200214 Nov
EPS$-0.34
Q2 200214 Aug
EPS$2.36
Q1 200220 May
EPS$-0.43
Q1 200212 Apr
EPS$-0.94
Q3 200114 Nov
EPS$-1.28
Q2 200114 Aug
EPS$-1.55
Q1 200111 May
EPS$-1.21
Q1 20012 Apr
EPS$-1.23
Q3 20007 Nov
EPS$-0.78
Q2 20009 Aug
EPS$-1.46
Q1 20009 May
EPS$-0.06
Q3 199926 Dec
EPS$-0.24
Q3 199912 Nov
EPS$-0.08
Q2 199911 Aug
EPS$-0.03
Q1 199930 Apr
EPS$-0.13
Q3 199831 Dec
EPS$-0.15
Q3 199812 Nov
EPS$-0.04
Q2 199828 Jul
EPS$-0.04
Q1 199819 May
EPS$-0.29
Q3 199731 Dec
EPS$-0.25
Q3 199713 Nov
EPS$-0.13
Q2 199718 Aug
EPS$-0.25
Q1 199712 May
EPS$-0.04
Q3 199614 Nov
EPS$-0.16
Q3 199615 Oct
EPS$-1.04
Q1 199614 May
EPS$-0.21
Q4 19959 Feb
EPS$-0.31
Q3 199514 Nov
EPS$-0.23
Q3 199513 Oct
EPS$-0.47
Q1 199515 May
EPS$-0.34
Q3 199431 Dec
EPS$-0.17
Q2 199430 Sept
EPS$-0.28
Q1 199430 Jun
EPS$-0.17
Q4 199331 Mar
EPS$-0.68
Q3 199331 Dec
EPS$-0.34
Q2 199330 Sept
EPS$-0.28
Q1 199330 Jun
EPS$-0.96
Q4 199231 Mar
EPS$-0.79
Q3 199231 Dec
EPS$-1.01
Q2 199230 Sept
EPS$-0.96
Q1 199230 Jun
EPS$-0.84
Q4 199131 Mar
EPS$-0.68
Q3 199131 Dec
EPS$-0.68
Q2 199130 Sept
EPS$-0.39
Q1 199130 Jun
EPS$-0.34
Q4 199031 Mar
EPS$-0.28
Q3 199031 Dec
EPS$-0.39
Q2 199030 Sept
EPS$-0.45
Q1 199030 Jun
EPS$-0.45
Q4 198931 Mar
EPS$-0.17
Q3 198931 Dec
EPS$-0.23
Q2 198930 Sept
EPS$-0.11
Q1 198930 Jun
EPS$-0.11
Q4 198831 Mar
EPS$-0.06
Q3 198831 Dec
EPS$-0.06
Q2 198830 Sept
EPS$-0.06

3 politicians traded within 30 days

No dividend data available for this stock.

Stock Splits

Split History

29 Jan 2014Reverse Split
Ratio1:14
16 Jun 2000Reverse Split
Ratio1:5

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about BLFS

Which members of Congress have traded BLFS?
1 member of Congress has disclosed 6 trade in BioLife Solutions Inc (BLFS) under the STOCK Act: Tom Malinowski.
When was BLFS most recently disclosed by Congress?
The most recent BLFS disclosure was a purchase by Tom Malinowski on 7 July 2020.
What is the total disclosed congressional trading volume for BLFS?
Members of Congress have disclosed approximately $121.5K in BLFS purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in BLFS?
This BLFS page updates as soon as new STOCK Act disclosures are filed for BioLife Solutions Inc. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.